Table 4.

SNHL and laboratory features at onset in patients with cCMV infection.

Features*	Asymptomatic patients (n = 102)	Symptomatic patients (n = 133)	p
SNHL	0 (0%)	85 (64%) Monolateral 29 (22%) Bilateral 56 (42%)	–
Plasma CMV DNA (positive)	49 (51%)	86 (62%)	p = 0.105
Plasma CMV DNA (copies/ml)	2,330 [95% C.I. 750–4,092] (range 178–49,600)	2,100 [95% C.I. 1,100–10,725] (range 160–11,300,000)	p = 0.16
Urinary CMV DNA (copies/ml)	776,349 [95% C.I. 69,500–3,135,000] (range 1,000–111,000,000)	243,101.5 [95% C.I. 100,000–1,982,500] (range 160–572,000,000)	p = 0.333
CSF CMV DNA (positive)	0/42 (0%)	13/84 (15%)	p = 0.005
CSF CMV DNA (copies/ml)	0	1,423 [95% C.I. 925–14,183] (range 160–58,000)	–

^*Values are expressed as absolute frequencies and percentages, mean ± standard deviation and range or median with range, as appropriate.